drugset / Trial / NCT03233880

Impact of Antichlamydial Treatment on the Rate of Preeclampsia

NCT03233880

Phase 4 Unknown 1200 enrolled Ain Shams Maternity Hospital
RandomizedParallel-groupDouble-blindPrevention

Summary

This randomized, double blinded controlled trial included 1200 healthy primigravidae who attended an outpatient clinic at 16-20weeks of pregnancy. All women were randomly divided equally into two groups, group A(600 women) who received antichlamydial treatment in the form of azithromycin 1 gram single oral dose before 20 weeks of pregnancy and group B (600 women) who received no treatment(placebo). All participants were followed up for up to 6 weeks postpartum and observed for the development of preeclampsia.

Timeline

Start
2016-07-01
Primary completion
2018-08-01
Completion
2018-08-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azithromycin Small molecule 1 g Oral

Indications